1 insider bought shares over the last 90 days, the latest filed 30 Sept 2026.
Iperionx Limited, classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to ASX. The last twelve months, up to 18 October 2026, brought 13 filings signed by 8 insiders.
Every open-market trade in the period is a purchase: 4 purchases worth €64k, from 3 insiders, and not a single sale. No amount is published for 2 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 3 senior executives among the declarants. R. Tony Tripeny filed the largest purchase, €61k, on 15 July 2026, which represents 0.0099% of the company's market value.
The clock since the last published purchase (30 September 2026) now reads 17 days.
With 13 filings in twelve months, the company is more active than the median of 3 filings across the 2,527 companies we follow on the same exchange. Looking back to 2026, when coverage begins, insiders filed 4 purchases and no sales.
In the same sector, recent insider purchases at Culp Inc also feature in our signals. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended June 2024 · cache
13 of 13 declarations
Iperionx Limited is a company focused on the chemistry and materials sector. It is listed on the Australian Securities Exchange (ASX).
Purchases our model currently ranks for the recommendations list.
All recommendations